课题基金 / 基金详情

Characterization of myeloid suppressor cell activity in experimental leishmaniasis

Characterization of myeloid suppressor cell activity in experimental leishmaniasis
实验性利什曼病骨髓抑制细胞活性的表征
批准号:
188763720
负责人:
Professor Dr. Uwe Ritter
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2013-12-31

项目摘要

项目成果

Professor Dr. Uwe Ritter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In experimental leishmaniasis, the clinical course of disease depends on the genetically determined ability of the infected mouse strain to mount a protective T cell-mediated immune response. C57BL/6 mice control parasite replication, whereas BALB/c mice develop a chronic course of disease. Considering these divergent phenotypes, it is most likely that parameters regulating the adaptive immune response against L. major parasites differ in C57BL/6 and BALB/c mice. Recently, myeloid suppressor cells have been described to suppress T cell functions. The most potent suppressive cells are inflammatory CD11b+ monocytes (IMC) that are characterized by the expression of high levels of lymphocyte antigen 6 complex C (Ly-6C), but are negative for Ly-6G. We quantified IMCs at the site of infection and skin-draining lymph nodes (SDLNs) of infected C57BL/6 and BALB/c mice. BALB/c mice showed an increase of IMC at the site of infection and SDLNs, whereas the numbers of IMCs in C57BL/6 SDLNs were not affected. Thus, we propose the hypothesis that IMCs migrate to the site of infection and SDLNs of BALB/c mice to suppress the development of an efficient T cell response. The overall goal of this project is to characterize the different T cell-suppressing mechanisms mediated by IMCs in the experimental model of leishmaniasis.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0139866
发表时间: 2015-10-21
期刊: PLOS ONE
影响因子: 3.7
作者: [Schmid, Maximilian, Dufner, Bianca, Ritter, Uwe]
通讯作者: Ritter, Uwe
Die regulatorische und pathologische Bedeutung von dendritischen Zellen für die T-Zell-vermittelte Immunantwort im experimentellen Modell der Leishmaniose
  • 批准号:
    37660748
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professor Dr. Uwe Ritter
  • 依托单位:
国内基金
海外基金
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
STAT3/IDO途径参与乳腺癌髓系来源抑制细胞(MDSCs)下调T细胞免疫及相关机制探讨
  • 批准号:
    81072159
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    于津浦
  • 依托单位: